Tag: physical sciences
-
Institute, GlaxoSmithKline ID Tuberculosis Candidates
13 October 2015. A biomedical research institute partnered with a lab backed by pharmaceutical company GlaxoSmithKline to identify candidates for drugs that act on bacteria causing tuberculosis. The team from Center for Infectious Disease Research in Seattle and Tres Cantos Open Lab Foundation, a lab in Spain sponsored by GlaxoSmithKline, published its findings in a…
-
Spin-Off to Provide Lower-Cost Molecular Imaging Technology
13 October 2015. A new enterprise based on research at Harvard University is offering a technology that allows ordinary microscopes to display high resolution images of single molecules. The company, Ultivue Inc., is founded by and licensing technologies from the lab of Peng Yin at Harvard’s Wyss Institute for Biologically Inspired Engineering. Yin and colleagues…
-
Breakout Labs Adds Four Science-Based Start-Ups
6 October 2015. Breakout Labs, an incubator of new enterprises based on discoveries from academic science labs, is adding four more companies to its portfolio. The new additions include companies developing advanced materials and sensors to measure food freshness, as well as discovering new therapies for diseases associated with the aging process. Breakout Labs is…
-
Self-Propelled Particles Designed to Stop Bleeding
2 October 2015. A biochemistry lab designed microscale particles that travel on their own through the body to stop heavy bleeding in trauma victims, surgery, and childbirth. Researchers at University of British Columbia in Vancouver, Canada led by biochemistry and engineering professor Christian Kastrup, published their findings in today’s issue of the journal Science Advances.…
-
Jet Fuel Additive Reduces Chance for Crash Explosions
2 October 2015. Materials scientists and chemists designed a polymer additive that reduces the explosive nature of jet fuel in crashes or terror attacks, without compromising the fuel’s performance. Researchers from California Institute of Technology and Jet Propulsion Laboratory in Pasadena published their findings in today’s issue of the journal Science (paid subscription required). The…
-
Nanotech Cancer Center Gains $10.1M Funding
1 October 2015. Cornell University and Memorial Sloan Kettering Cancer Center are developing cancer diagnostics and therapies with nanoscale particles, funded largely by a National Cancer Institute grant. NCI, part of National Institutes of Health, is providing $8.2 million to the institutions over five years, while Sloan Kettering is adding $1.9 million. Cornell and Sloan…
-
NASA to Test Hand-Held DNA Sequencer in Space Station
30 September 2015. Astronauts aboard the International Space Station will take part in experiments testing the feasibility of a portable DNA sequencing device in space. The proof-of-concept test of the hand-held MinIon DNA sequencing device is a project of National Aeronautics and Space Administration. The MinIon, made by Oxford Nanopore Technologies in the U.K., is…
-
Sensor Network, Google Maps to Track California Air Quality
28 September 2015. A San Francisco company that designs environmental sensors and networks is partnering with Google Maps to track air quality in three California regions. Aclima Inc. and Google Maps announced the partnership today at the annual meeting of the Clinton Global Initiative in New York, but no financial details were revealed. Aclima Inc. develops…
-
Hydrogel Aids Stem Cells Repair Heart Functions
25 September 2015. Tissue engineers and medical researchers at Johns Hopkins University developed a gel material that holds and supports the work of stem cells in repairing heart damage in lab animals. The team led by cardiologist Marie Roselle Abraham and medical materials scientist Jennifer Elisseeff published its findings earlier this month in the journal…
-
Clinical Trial Underway Testing Cancer Surgery Aid
22 September 2015. A clinical trial is enrolling patients with soft tissue sarcoma to test a synthetic peptide that illuminates cancer cells to make them more easily removed during surgery. The early-stage study is testing the safety of the peptide made by Blaze Bioscience Inc. in Seattle and conducted at Cedars-Sinai Medical Center in Los…